Warnings

Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial

Background Whether intravenous tissue plasminogen activator (alteplase) is effective beyond 3 h after onset of acute...

2008-02-27

Health Canada warns against Foreign Products use

On February 07, 2008, Health Canada, the Canadian equivalent to the Saudi Food and Drug Authority (SFDA), adviced...

2008-02-13

New warnings about serious adverse events with botulinum toxin (Botox) in the U.S.

On February 8, 2008, The U.S. Food and Drug Administration (FDA), the American equivalent of the Saudi Food and Drug...

2008-02-13

U.S. FDA Takes Action to Stop the Marketing of Unapproved Injectable Drugs Containing Colchicine

On February 6, 2008, the U.S. Food and Drug Administration (FDA), the American equivalent to the Saudi Food and Drug...

2008-02-12

Suicidality and Antiepileptic Drugs; An FDA Alert

On January 31, 2008, the U.S. Food and Drug Administration (FDA) , the American equivalent to the Saudi Food and Drug...

2008-02-06

Hepatic Reactions with Terbenafine

The Australian Therapeutic Goods Administration (TGA), the Australian equivalent to the Saudi Food and Drug Authority...

2008-02-06

Serious neuropsychiatric symptoms experienced in patients taking Chantix™

On February 1, 2008, The U.S Food and Drug Administration (FDA), the equivalent of the Saudi Food and Drug Authority...

2008-02-06

Fluoroquinolone Antibiotics & Psychiatric Adverse Drug Reactions

Prescrire International, a highly regarded French drug bulletin, published a review of psychiatric adverse effects...

2008-02-06

Serious Safety concerns with the use of Edetate Disodium

January 16, 2008 – The U.S Food and Drug Administration (FDA), the equivalent of the Saudi Food and Drug Authority (SFDA...

2008-01-20